Symbiotec Pharmalab shares to list today; GMP signals 19% premium
Symbiotec Pharmalab shares are set to list today, with GMP signaling a 19% premium over the IPO price.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.